BCL-2 Inhibition in the Treatment of Multiple Myeloma

Gabor Mikala
Additional contact information
Gabor Mikala: Department of Haematology and Stem Cell Transplantation South-Pest Central Hospital, National Institute for Haematoloy and Infectious Diseases, Hungary

Biomedical Journal of Scientific & Technical Research, 2018, vol. 4, issue 4, 4058-4060

Abstract: Multiple myeloma is the second most common haematological malignancy – though multiple effective therapeutic options exist for disease control – cure of myeloma still remains the exception...

Keywords: Biomedical Sciences; Biomedical Research; Technical Research (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.001087.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.001087.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:4:y:2018:i:4:p:4058-4043

DOI: 10.26717/BJSTR.2018.4.001087

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().